147 related articles for article (PubMed ID: 9302439)
1. Co-expression of CXCR4/fusin and galactosylceramide in the human intestinal epithelial cell line HT-29.
Delézay O; Koch N; Yahi N; Hammache D; Tourres C; Tamalet C; Fantini J
AIDS; 1997 Sep; 11(11):1311-8. PubMed ID: 9302439
[TBL] [Abstract][Full Text] [Related]
2. Sulfatide inhibits HIV-1 entry into CD4-/CXCR4+ cells.
Fantini J; Hammache D; Delézay O; Piéroni G; Tamalet C; Yahi N
Virology; 1998 Jul; 246(2):211-20. PubMed ID: 9657940
[TBL] [Abstract][Full Text] [Related]
3. Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor.
Fantini J; Cook DG; Nathanson N; Spitalnik SL; Gonzalez-Scarano F
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2700-4. PubMed ID: 8464878
[TBL] [Abstract][Full Text] [Related]
4. Suramin inhibits binding of the V3 region of HIV-1 envelope glycoprotein gp120 to galactosylceramide, the receptor for HIV-1 gp120 on human colon epithelial cells.
Yahi N; Sabatier JM; Nickel P; Mabrouk K; Gonzalez-Scarano F; Fantini J
J Biol Chem; 1994 Sep; 269(39):24349-53. PubMed ID: 7929093
[TBL] [Abstract][Full Text] [Related]
5. A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains.
Berson JF; Long D; Doranz BJ; Rucker J; Jirik FR; Doms RW
J Virol; 1996 Sep; 70(9):6288-95. PubMed ID: 8709256
[TBL] [Abstract][Full Text] [Related]
6. A monoclonal antibody (12G5) directed against CXCR-4 inhibits infection with the dual-tropic human immunodeficiency virus type 1 isolate HIV-1(89.6) but not the T-tropic isolate HIV-1(HxB).
Strizki JM; Turner JD; Collman RG; Hoxie J; González-Scarano F
J Virol; 1997 Jul; 71(7):5678-83. PubMed ID: 9188648
[TBL] [Abstract][Full Text] [Related]
7. CD4-independent infection by HIV-2 is mediated by fusin/CXCR4.
Endres MJ; Clapham PR; Marsh M; Ahuja M; Turner JD; McKnight A; Thomas JF; Stoebenau-Haggarty B; Choe S; Vance PJ; Wells TN; Power CA; Sutterwala SS; Doms RW; Landau NR; Hoxie JA
Cell; 1996 Nov; 87(4):745-56. PubMed ID: 8929542
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR4) is both cell type and virus strain dependent.
McKnight A; Wilkinson D; Simmons G; Talbot S; Picard L; Ahuja M; Marsh M; Hoxie JA; Clapham PR
J Virol; 1997 Feb; 71(2):1692-6. PubMed ID: 8995702
[TBL] [Abstract][Full Text] [Related]
9. Synthetic multimeric peptides derived from the principal neutralization domain (V3 loop) of human immunodeficiency virus type 1 (HIV-1) gp120 bind to galactosylceramide and block HIV-1 infection in a human CD4-negative mucosal epithelial cell line.
Yahi N; Sabatier JM; Baghdiguian S; Gonzalez-Scarano F; Fantini J
J Virol; 1995 Jan; 69(1):320-5. PubMed ID: 7983725
[TBL] [Abstract][Full Text] [Related]
10. Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines.
Lapham CK; Ouyang J; Chandrasekhar B; Nguyen NY; Dimitrov DS; Golding H
Science; 1996 Oct; 274(5287):602-5. PubMed ID: 8849450
[TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus strains differ in their ability to infect CD4+ cells expressing the rat homolog of CXCR-4 (fusin).
Pleskoff O; Sol N; Labrosse B; Alizon M
J Virol; 1997 Apr; 71(4):3259-62. PubMed ID: 9060691
[TBL] [Abstract][Full Text] [Related]
12. CXCR4/fusin is not a species-specific barrier in murine cells for HIV-1 entry.
Tachibana K; Nakajima T; Sato A; Igarashi K; Shida H; Iizasa H; Yoshida N; Yoshie O; Kishimoto T; Nagasawa T
J Exp Med; 1997 May; 185(10):1865-70. PubMed ID: 9151712
[TBL] [Abstract][Full Text] [Related]
13. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1.
Oberlin E; Amara A; Bachelerie F; Bessia C; Virelizier JL; Arenzana-Seisdedos F; Schwartz O; Heard JM; Clark-Lewis I; Legler DF; Loetscher M; Baggiolini M; Moser B
Nature; 1996 Aug; 382(6594):833-5. PubMed ID: 8752281
[TBL] [Abstract][Full Text] [Related]
14. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes.
Bleul CC; Wu L; Hoxie JA; Springer TA; Mackay CR
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1925-30. PubMed ID: 9050881
[TBL] [Abstract][Full Text] [Related]
15. Primary human mammary epithelial cells endocytose HIV-1 and facilitate viral infection of CD4+ T lymphocytes.
Dorosko SM; Connor RI
J Virol; 2010 Oct; 84(20):10533-42. PubMed ID: 20702626
[TBL] [Abstract][Full Text] [Related]
16. Membrane glycolipids and human immunodeficiency virus infection of primary macrophages.
Seddiki N; Ben Younes-Chennoufi A; Benjouad A; Saffar L; Baumann N; Gluckman JC; Gattegno L
AIDS Res Hum Retroviruses; 1996 May; 12(8):695-703. PubMed ID: 8744580
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma decreases cell surface expression of galactosyl ceramide, the receptor for HIV-1 GP120 on human colonic epithelial cells.
Yahi N; Spitalnik SL; Stefano KA; De Micco P; Gonzalez-Scarano F; Fantini J
Virology; 1994 Nov; 204(2):550-7. PubMed ID: 7941321
[TBL] [Abstract][Full Text] [Related]
18. A new possible mechanism of human immunodeficiency virus type 1 infection of neural cells.
Alvarez Losada S; Cantó-Nogués C; Muñoz-Fernández MA
Neurobiol Dis; 2002 Dec; 11(3):469-78. PubMed ID: 12586555
[TBL] [Abstract][Full Text] [Related]
19. Specific interaction of HIV-1 and HIV-2 surface envelope glycoproteins with monolayers of galactosylceramide and ganglioside GM3.
Hammache D; Piéroni G; Yahi N; Delézay O; Koch N; Lafont H; Tamalet C; Fantini J
J Biol Chem; 1998 Apr; 273(14):7967-71. PubMed ID: 9525894
[TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of a monoclonal antibody that inhibits HIV-1 infection.
Fu DX; Jinno A; Shimizu N; Haraguchi Y; Hoshino H
Microbes Infect; 1999 Jul; 1(9):677-84. PubMed ID: 10611745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
